Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

HHS reveals overarching ‘AI ambition,’ lays out strategy for pursuing it

HHS has published a document that it says marks the department’s first concerted move to transform itself into an “AI-fueled enterprise.”

10 notable FDA approvals of AI* in medical devices over the past 90 days

*May also include VR/AR and 3D printing. Links lead to announcements as sent by the companies.

Thumbnail

Biden to undo Trump-era healthcare policies

The Biden-Harris administration is planning to sign two executive orders to provide healthcare relief for those needing insurance during the COVID-19 pandemic, as well as undo some Trump administration policies that undermined the Affordable Care Act.

More evidence hospitals grudgingly complying on price transparency for ‘shoppable services’

Another quick field check has found the federal rule requiring hospitals to show their prices for shoppable services meeting with only spotty compliance since it went into effect Jan. 1.

Thumbnail

Large health system paying record $7.75M for carelessness with pain pills

Fifteen-hospital McLaren Health Care has agreed to pay $7.75 million for illegally distributing prescription painkillers. 

Thumbnail

Burnout in healthcare workers quantifiable, reduceable

Primary care practices battling burnout would do well to build capacity for adapting to change—taking charge of volatility rather than reacting to it—especially in times of widespread crisis.

NIH-led COVID research effort taps AI startup schooled in synthetic health data

The NIH, FDA and Bill and Melinda Gates Foundation are working with a San Francisco startup whose calling card is an AI-enabled engine that renders patient data unidentifiable by reproducing it in synthetic versions.

FDA going soft on AI reviews?

Last Tuesday the FDA posted an action plan telling how it will evaluate AI for medical applications going forward. Three days later the agency officially proposed letting numerous products through without review. 

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup